RS KHZ Musthafa Achieves Breakthrough in Rapid Stroke Treatment

RS KHZ Musthafa in Tasikmalaya successfully treated two stroke patients, a 74-year-old man and a 37-year-old woman, who returned to normal health in under five hours. According to neurologist dr. Indra, Sp.S, the recovery followed the rapid administration of Trombolysis medication by the hospital’s specialized “Code Stroke” team.

How did the medical team achieve these results?

The recovery was possible because the “Code Stroke” team acted quickly and accurately, according to dr. Indra. The hospital had just received a supply of Trombolysis medication on Wednesday afternoon, which is a primary treatment for stroke attacks.

Dr. Indra noted that Trombolysis treatment is a race against time. Patients must receive medical intervention within a “golden period,” defined as less than 4 hours and 30 minutes from the start of the attack.

When treatment occurs within this window, dr. Indra stated the potential for a patient to return to normal is very high, ranging between 90 and 95 percent. This process requires a solid, supportive team to ensure the effectiveness of the standard operating procedures.

Did You Know? Based on hospital data, Tasikmalaya sees approximately 1,000 stroke patients every year.

What is the current status of the patients?

Both patients, identified as S (74) and N (37), remain under strict 24-hour medical supervision to maximize their recovery. Dr. Indra detailed a rigorous monitoring schedule for the patients.

Medical staff monitored the patients every 15 minutes during the first two hours. For the following six hours, checks occurred every 30 minutes, followed by hourly monitoring for the remainder of the period.

Expert Insight: Samantha Carter notes that the strict adherence to the “golden period” underscores the critical nature of time-sensitive interventions in neurology. The success here highlights how the availability of specific pharmaceuticals, combined with a coordinated rapid-response team, can directly alter patient outcomes.

Why is this development significant for Tasikmalaya?

Hospital Director dr. Hj. Elin Hendalia, MH.Kes, stated that providing Trombolisis medication is a commitment to improving public service quality. This decision responds to the high volume of stroke cases in the Tasikmalaya region.

The availability of this medication and the readiness of the medical team may provide a new solution and hope for total recovery for future stroke sufferers in the area.

What may happen next?

With the established “Code Stroke” protocol, RS KHZ Musthafa could see more patients recovering within the golden period. The hospital’s ability to maintain a supply of Trombolysis medication is likely to be a key factor in treating the roughly 1,000 annual cases reported by dr. Elin.

Frequently Asked Questions

What is the “golden period” for stroke treatment?
According to dr. Indra, the golden period is less than 4 hours and 30 minutes from the onset of the stroke attack.

What medication was used to treat the patients?
The medical team used Trombolysis medication, which dr. Indra described as one of the primary drugs for treating stroke attacks.

What is the success rate of treatment within the golden period?
Dr. Indra stated that the potential for a patient to return to normal is between 90 and 95 percent if treated quickly.

How important is rapid response in your local healthcare system?